Re: ZEN-3694 and Enzalutamide 2b Trial

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ZEN-3694 and Enzalutamide 2b Trial

in response to

ZEN-3694 and Enzalutamide 2b Trial

RVXoldtimer

posted on Apr 22, 2021 11:11AM

"The clinical study is expected to start in Q2 2021."

Do we know the duration of the Phase 2b randomized study?

Koo

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply